Early Tumour Response for Cervical Cancer Patients with Anteroposterior Separation Greater than 21cm Treated using a Four-Field Technique on Cobalt Teletherapy

Read full text Summarise with VIRAT
Authors: Elizabeth Njovu, Oliver Sutherland, Stefan Kafwimbi, Phanny Nankonde, James Sichone
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: Treatment of locally advanced cervical cancer requires the use of radiotherapy. The tumour response rate measured midway through radiotherapy provides valuable prognostic information. This study sought to document the dose distribution and early tumor response in patients treated with cobalt teletherapy at Cancer Diseases Hospital (CDH). The objective was to determine the effectiveness of Cobalt Teletherapy in the treatment of cervical cancer patients at CDH with an anteroposterior separation of 21 cm and above using the four-field technique. Methodology: The study employed a cross-sectional design. Population was patient treatment files. All files fitting the criteria were included. Dose distribution and treatment response assessment data was retrieved and analysed. Descriptive and inferential statistics were run for the analysis. Results: There was a significant association between tumour size, the level of haemoglobin, and the number of fractions received during External Beam Radiotherapy (EBRT) (p0.05). Other factors not significantly associated with tumour size reduction include Parity HIV status, Performance status, Average radiation dose, field size, number of chemotherapy circles, chemotherapy type. Conclusion: There is contextual evidence that tumour can reduce in size with an increase in number of fractions received during EBRT and level of haemoglobin. AP separation, Age, Parity, HIV status, Performance status, Average radiation dose, field size, number of chemotherapy circles, chemotherapy type, and Dose to the 95% isodose line did not show any effect on cervical tumour size (p>0.05).

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Advanced Radiotherapy Techniques Advances in Oncology and Radiotherapy

Publication details

Journal / source
EAS Journal of Anaesthesiology and Critical Care
Volume
8
Issue
02
Pages
82–87
Publication date
20 March 2026
Language
EN